Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task.

Ringman JM, Medina LD, Braskie M, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer S.

Cereb Cortex. 2011 Apr;21(4):877-83. doi: 10.1093/cercor/bhq158. Epub 2010 Aug 20.

PMID:
20729396
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G.

Brain. 2007 Jul;130(Pt 7):1767-76. Epub 2007 May 23.

PMID:
17522104
[PubMed - indexed for MEDLINE]
Free Article
3.

Assessment of Alzheimer's disease risk with functional magnetic resonance imaging: an arterial spin labeling study.

Bangen KJ, Restom K, Liu TT, Wierenga CE, Jak AJ, Salmon DP, Bondi MW.

J Alzheimers Dis. 2012;31 Suppl 3:S59-74.

PMID:
22531427
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.

Am J Psychiatry. 2006 Sep;163(9):1603-10.

PMID:
16946187
[PubMed - indexed for MEDLINE]
5.

Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study.

Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC.

BMC Med. 2006 Jan 13;4:1.

PMID:
16412236
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Interactive effect of apolipoprotein e genotype and age on hippocampal activation during memory processing in healthy adults.

Nichols LM, Masdeu JC, Mattay VS, Kohn P, Emery M, Sambataro F, Kolachana B, Elvevåg B, Kippenhan S, Weinberger DR, Berman KF.

Arch Gen Psychiatry. 2012 Aug;69(8):804-13. doi: 10.1001/archgenpsychiatry.2011.1893.

PMID:
22868934
[PubMed - indexed for MEDLINE]
7.

Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillón G, Lopera F, Stern CE.

Ann Neurol. 2010 Dec;68(6):865-75. doi: 10.1002/ana.22105. Erratum in: Ann Neurol. 2011 Jul;70(1):187.

PMID:
21194156
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.

Ringman JM, Elashoff D, Geschwind DH, Welsh BT, Gylys KH, Lee C, Cummings JL, Cole GM.

Arch Neurol. 2012 Jun;69(6):757-64. doi: 10.1001/archneurol.2012.277.

PMID:
22689192
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.

Trachtenberg AJ, Filippini N, Cheeseman J, Duff EP, Neville MJ, Ebmeier KP, Karpe F, Mackay CE.

Neurobiol Aging. 2012 Mar;33(3):618.e1-618.e13. doi: 10.1016/j.neurobiolaging.2010.11.011. Epub 2011 Jan 12.

PMID:
21232817
[PubMed - indexed for MEDLINE]
10.

Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers.

Lind J, Persson J, Ingvar M, Larsson A, Cruts M, Van Broeckhoven C, Adolfsson R, Bäckman L, Nilsson LG, Petersson KM, Nyberg L.

Brain. 2006 May;129(Pt 5):1240-8. Epub 2006 Mar 14.

PMID:
16537568
[PubMed - indexed for MEDLINE]
Free Article
11.

Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.

Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K.

Brain. 2006 Nov;129(Pt 11):2908-22. Epub 2006 Sep 29.

PMID:
17012294
[PubMed - indexed for MEDLINE]
Free Article
12.

Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.

Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Thompson PM, Cummings JL, Bookheimer SY, Ringman JM.

Hum Brain Mapp. 2013 Dec;34(12):3308-19. doi: 10.1002/hbm.22141. Epub 2012 Jul 17.

PMID:
22806961
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Patterns of brain activation in people at risk for Alzheimer's disease.

Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW.

N Engl J Med. 2000 Aug 17;343(7):450-6.

PMID:
10944562
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.

Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Gilbert PE, Liang LJ, Cummings JL, Ringman JM.

Dement Geriatr Cogn Disord. 2011;32(3):188-92. doi: 10.1159/000333023. Epub 2011 Aug 30.

PMID:
22134129
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Xu G, McLaren DG, Ries ML, Fitzgerald ME, Bendlin BB, Rowley HA, Sager MA, Atwood C, Asthana S, Johnson SC.

Brain. 2009 Feb;132(Pt 2):383-91. doi: 10.1093/brain/awn254. Epub 2008 Oct 1.

PMID:
18829694
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation.

Bobes MA, García YF, Lopera F, Quiroz YT, Galán L, Vega M, Trujillo N, Valdes-Sosa M, Valdes-Sosa P.

Hum Brain Mapp. 2010 Feb;31(2):247-65. doi: 10.1002/hbm.20861.

PMID:
19650138
[PubMed - indexed for MEDLINE]
17.

Functional MRI assessment of task-induced deactivation of the default mode network in Alzheimer's disease and at-risk older individuals.

Pihlajamäki M, Sperling RA.

Behav Neurol. 2009;21(1):77-91. doi: 10.3233/BEN-2009-0231.

PMID:
19847047
[PubMed - indexed for MEDLINE]
18.

The effects of APOE-ε4 on the BOLD response.

Trachtenberg AJ, Filippini N, Mackay CE.

Neurobiol Aging. 2012 Feb;33(2):323-34. doi: 10.1016/j.neurobiolaging.2010.03.009. Epub 2010 Apr 20. Review.

PMID:
20409610
[PubMed - indexed for MEDLINE]
19.

The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE ε3/ε3 genotype.

Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA.

Alzheimers Dement. 2011 Jul;7(4):456-65. doi: 10.1016/j.jalz.2010.11.012.

PMID:
21784354
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.

Klages JD, Fisk JD, Rockwood K.

Dement Geriatr Cogn Disord. 2003;15(1):1-5.

PMID:
12457072
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk